Gabapentin
Gabapentin is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Gabapentin; Generic name: GABAPENTIN; Manufacturer: ScieGen Pharmaceuticals, Inc..
| Brand name | Gabapentin |
|---|---|
| Generic name | GABAPENTIN |
| Manufacturer | ScieGen Pharmaceuticals, Inc. |
| Used for | 1 INDICATIONS AND USAGE Gabapentin is indicated for: Management of postherpetic neuralgia in adults Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy Gabapentin is indicated for: Postherpetic neuralgia in adults ( 1 ) Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy ( 1 ) |
| Dosage | 2 DOSAGE AND ADMINISTRATION Postherpetic Neuralgia ( 2.1 ) o Dose can be titrated up as needed to a dose of 1800 mg/day o Day 1: Single 300 mg dose o Day 2: 600 mg/day (i.e., 300 mg two times a day) o Day 3: 900 mg/day (i.e., 300 mg three times a day) Epilepsy with Partial Onset Seizures ( 2.2 ) Patients 12 years of age and older: starting dose is 300 mg three times daily; may be titrated up to 600 mg three times daily Patients 3 to 11 years of age: starting dose range is 10 to 15 mg/kg/day, giv |
| Active ingredient(s) | GABAPENTIN |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=16542ee6-0e0e-4d3c-8b32-60ff6ef48846 |